NCT03983967View on ClinicalTrials.gov

Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

January 24, 2019

Primary Completion Date

September 9, 2021

Study Completion Date

August 30, 2022

Conditions
Liver Transplantation
Interventions
BIOLOGICAL

Immuncell-LC

Activated T lymphocyte

Trial Locations (1)

110-744

Seoul National Hospital, Seoul

Sponsors
All Listed Sponsors
lead

GC Cell Corporation

INDUSTRY

NCT03983967 - Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation | Biotech Hunter | Biotech Hunter